Please ensure Javascript is enabled for purposes of website accessibility

Down 40%, Is Teladoc a Buy Right Now?

By Neil Rozenbaum - Apr 27, 2021 at 11:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Telehealth isn't going away anytime soon.

This video will discuss Teladoc (TDOC 0.00%) and why I believe this company has a bright future, despite the stock being down 40% since its all-time highs in February. The company is expected to report Q1 earnings on Wednesday, April 28, after the market close. 

Quick recap

Teladoc makes telemedicine simple. instead of taking a day off work or school, you can use Teladoc. Book a visit through your phone, find a doctor near you, and talk via webcam. If you need a prescription, your doctor will send it to the nearest pharmacy, and when you arrive it'll be ready for you. 

Teladoc bought Livongo for $18.5 billion last year. Livongo devices send you signals and monitor chronic diseases. Elevated heart rate? You'll get notified to relax and take a breath. If you do not feel well, book a visit, and the doctor will get all the needed info directly from the Livongo device. 

What to expect in 2021

Q4 revenue grew 145% year over year to $383.3 million, and total visits increased 139% to 3.0 million. Full-year revenue grew 98% year over year to $1,094.0 million, and total visits increased 156% to 10.6 million.

Teladoc expects total revenue to be in the range of $1.95 billion to $2.0 billion for the full year 2021 and total revenue to be in the range of $445 million to $455 million for the first quarter of 2021.

*Stock prices used were the closing prices of April 26, 2021. The video was published on April 27, 2021.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$38.81 (0.00%) $0.00
Livongo Health, Inc. Stock Quote
Livongo Health, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.